SGK1 and Cerebral ischemia: Inhibition of SGK1 by the SGK1 inhibitor GSK650394 has been found to reduce infarct size and blood-brain barrier disruption in ischemia-reperfusion injury during the early phase of cerebral ischemia, thereby protecting brain function (Chi et al., 2021).